Novo Nordisk reports 21% profit jump in 2024


Danish drugmaker Novo Nordisk, maker of the blockbuster diabetes and weight-loss treatments Ozempic and Wegovy, said Wednesday its net profit rose 21% to 100 billion Danish kroner ($13.9 billion) last year.
Europe's most valuable company also reported a 25% increase in sales, reaching 290.4 billion Danish kroner.
A traditional dish called zongzi is served during China’s Dragon Boat Festival, which falls in June. It is a rice…
Divina credited the firm’s achievements to its members, thanking them for their ‘hard work, dedication, teamwork, and…
‘Sec. Vince Dizon, please explain how this finding of your own team should not be flagged as a ghost project in Taguig.’